Professor Dame Til Wykes receives Constance Pascal-Helen Boyle Prize
The European Psychiatric Association (EPA) has announced Professor Dame Til Wykes as the winner...
European Prevention of Alzheimer’s Dementia Newsletter February 2020
Dear Friends and Colleagues, It’s February 2020 and we are just weeks away from...
Learning more about the role of mitochondrial dysfunction in Parkinson’s to help develop better therapies
New, more effective treatments are urgently needed for the more than one million people...
Neuronet convenes third Scientific Coordination Board meeting in Madrid
On 28 January (Madrid, Spain), Neuronet convened its 3rd Scientific Coordination Board meeting. The...
AETIONOMY project finalises sustainability agreement for knowledge base, data and sample sharing
The AETIONOMY project (Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug...
Second Neuronet newsletter issue launched
Welcome to the second issue of the Neuronet newsletter! This second newsletter issue provides...
Spotlight on early-career researchers: a Neuronet interview with Tania Fowke and Shahzad Ahmad
Neuronet spoke to two early-career researchers (ECRs) working on the Innovative Medicines Initiative’s ADAPTED...
PD-MitoQUANT Principal Investigators organise conference on the pathophysiology of Parkinson’s disease
Prinicpal Investigators of the Innovative Medicines Initative’s PD-MitoQUANT project Olga Corti, Stéphane Hunot (both...
Alzheimer Europe Lunch Debate focusses on improving the diagnosis of dementia
On 10 December, two Innovative Medicines Initiative projects participated in an Alzheimer Europe Lunch...
Spotlight on early-career researchers: a Neuronet interview with Lianne Reus
Interview with Lianne Reus, PhD candidate at Amsterdam UMC focusing on social withdrawal in...
Spotlight on EPAD study site Fundació ACE
The team of Dr. Mercè Boada began recruiting in June 2019 and has...
EPAD V1500.0 dataset is now available for EPAD researchers
The Innovative Medicines Initiative‘s EPAD (European Prevention of Alzheimer’s Dementia Consortium) announced the internal...
Highlights of PD-MitoQUANT Plenary Meeting
At the sunny coastal town of Herzeliya, Israel, over 35 participants from 8 countries...
The European Prevention of Alzheimer’s Dementia Consortium releases its first wave of data
The European Prevention of Alzheimer’s Dementia (EPAD), a major Europe-wide initiative aiming to improve...
Spotlight on early-career investigators: an interview with Benjamin Falcon
Dr Benjamin Falcon is a postdoctoral scientist at the UK Medical Research Council Laboratory...
Neuronet meeting focuses on key assets and collaborations of IMI neurodegeneration projects
On 20 November (Madrid, Spain), Neuronet held a team meeting on key assets with...
AETIONOMY results presented to Innovative Medicines Initative leadership
AETIONOMY started five years ago exploring the idea that conventional disease definition is an...
PHAGO project holds 4th General Assembly Meeting in Erl Wood
With the PHAGO (Inflammation and Alzheimer’s disease: modulating microglia function – focussing on TREM2...
EPAD webinar by KNect365 is now available
As part of the Clinical Trials Digital Week, KNect365 Life Sciences organised a global...
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings...